Companies / Malaysia
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Malaysian Drug Market Forges Ahead
June 2006 | Industry ForecastSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
As a focal point of regional-sector development, the Malaysian pharmaceutical market is expected to grow robustly in the short term. The pharmaceutical industry is currently valued at nearly US$1bn, growing at a steady rate of 8-9% annually. The country still imports more than half of its pharmaceuticals and medical equipment, mostly from the US, Japan and Germany. The Malaysian government has placed the country's healthcare industry as one of its top priorities, and continually strives to implement new schemes to help boost the country's medical sector.